Table 3.
Medication | Pre-Conception | References |
---|---|---|
Hydroxychloroquine | Recommended to all patients | [5,15,46] |
Oral glucocorticoids | Accepted if needed at lowest effective dose, but less than 20 mg/day equivalent Prednisone | [5,15,46] |
Azathioprine | Accepted if needed | [5,15,46] |
Cyclosporin A and tacrolimus | Accepted if needed, caution if high blood pressure | [5,15,46] |
Nonsteroidal antiinflamatory drugs | Accepted if needed, discontinue if there is problem with conceiving, cyclooxygenase 2 not indicated | [5,15,46] |
Methotrexate | Stop 1–3 months prior to conception | [5,15,46] |
Leflunomide | Stop if planning a pregnancy, washout with cholestyramine until no longer detected | [5,15,46] |
Mycophenolate Mofetil and Mycophenolic Acid | Stop at least 6 weeks before conception to observe flare after discontinuation | [5,15,46] |
Cyclophosphamide | Stop 3 months prior to conception | [5,15,46] |
Available biologics (Belimumab, Rituximab) | Discontinue at conception | [15] |
Recently approved biologic (Anifrolumab) | Not yet included in EULAR and ACR recommendations, no available data related to safety during pregnancy |
EULAR—European Alliance of Associations for Rheumatology; ACR—American College of Rheumatology.